Clinical Trials Browser

Glioblastoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Glioblastoma, Glioma

Glioma, Neoplasms

Glioblastoma, Glioma

Glioblastoma

Low-grade Glioma

Brain Neoplasms, Meningioma

Glioblastoma

Glioblastoma

Glioblastoma, Glioma

Neurofibromatosis 2

Meningeal Carcinomatosis

Glioblastoma

Choroid Plexus Carcinoma, Glioma, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Brain Neoplasms, Glioblastoma

Brain Neoplasms

Glioblastoma

Glioblastoma

Neurofibromatosis 1, Neurofibroma, Plexiform

Brain Neoplasms

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

Glioblastoma

Glioblastoma

Brain Neoplasms

Hodgkin Disease, Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma, Central Nervous System Neoplasms

Neuroblastoma

Glioblastoma

Neuroblastoma

Glioblastoma

Clinical Trials

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

CIPHER

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

ADePT

A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

OPTICAL

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

IMED-GLOW400

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Cerebraca-02/3

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

EARLYBRAINPET

A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY PROCESSOR CCELL (CONFOCAL FLUORESCENCE ENDOMICROSCOPY) FOR INTRAOPERATIVE DIAGNOSIS IN BRAIN TUMORS

A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor

IMED-MYVEO

NG101m Adjuvant Therapy in Glioblastoma Patients

Phase 2 Clinical Trial of KH617

IMAGLIO

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

VICTORIA

PRECISION

Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Targeted Survivin DC Cell Injection for the Treatment of GBM

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Navigating the Clinical Research Process for Glioma

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Determining Patterns In Study Experiences of Neuroblastoma Patients

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab